Life-space mobility is associated with frequency of hospitalization in adults with cystic fibrosis

Clinical Respiratory Journal

Volumn 5, Issue 4, 2011, Pages 245-251

  Gottlieb, Eric Raphael ^a   Smith, Elisabeth Christine ^a   Wolfenden, Linda Lucetta ^a,b   Allman, Richard Mark ^c   Tangpricha, Vin ^a,b,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Cystic fibrosis; Life space mobility; Quality of life

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; LIFE SPACE ASSESSMENT; MALE; PATIENT MOBILITY; PRIORITY JOURNAL;

ADULT; BODY MASS INDEX; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; WALKING;

EID: 80052999696     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/j.1752-699X.2010.00225.x     Document Type: Article

References (30)

1. Accurso FJ. Update in cystic fibrosis 2006. Am J Respir Crit Care Med. 2007;175: 754-7.
2. Belkin RA, Henig NR, Singer LG, etal. Risk factors for death of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med. 2006;173: 659-66.
3. Liou T, Adler F, FitzSimmons S, Cahill B, Hibbs J, Marshall B. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol. 2001;153: 345.
4. Zemanick ET, Harris JK, Conway S, etal. Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy. J Cyst Fibros. 2009;9(1): 1-16.
5. Block JK, Vandemheen KL, Tullis E, etal. Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. Thorax. 2006;61: 969-74.
6. Amadori A, Antonelli A, Balteri I, Schreiber A, Bugiani M, De Rose V. Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis. Respir Med. 2009;103: 407-13.
7. Quittner AL, Butt A, Messer MA, Modi AC, Watrous M. Development and validation of the cystic fibrosis questionnaire in the United States - a health-related quality-of-life measure for cystic fibrosis. Chest. 2005;128: 2347-54.
8. Goss CH, Edwards TC, Ramsey BW, Aitken ML, Patrick DL. Patient-reported respiratory symptoms in cystic fibrosis. J Cyst Fibros. 2009;8: 245-52.
9. Gee L, Abbott J, Conway SP, Etherington C, Webb AK. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax. 2000;55: 946-54.
10. Goldbeck L, Schmitz TG, Heinrich G, Herschbach P. Questions on life satisfaction for adolescents and adults with cystic fibrosis - development of a disease-specific questionnaire. Chest. 2003;123: 42-8.
11. Orenstein DM, Nixon PA, Ross EA, Kaplan RM. The quality of well-being in cystic-fibrosis. Chest. 1989;95: 344-7.
12. Schneiderman-Walker J, Wilkes DL, Strug L, etal. Sex differences in habitual physical activity and lung function decline in children with cystic fibrosis. J Pediatr. 2005;147: 321-6.
13. Wilkes DL, Schneiderman JE, Nguyen T, etal. Exercise and physical activity in children with cystic fibrosis. Paediatr Respir Rev. 2009;10: 105-9.
14. Peel C, Baker P, Roth D, Brown C, Bodner E, Allman R. Assessing mobility in older adults: the UAB Study of Aging Life-Space Assessment. Phys Ther. 2005;85: 1008.
15. Brown CJ, Roth DL, Allman RM, Sawyer P, Ritchie CS, Roseman JM. Trajectories of life-space mobility after hospitalization. Ann Intern Med. 2009;150: 372-8.
16. Crowe M, Andel R, Wadley VG, Okonkwo OC, Sawyer P, Allman RM. Life-space and cognitive decline in a community-based sample of African American and Caucasian older adults. J Gerontol A Biol Sci Med Sci. 2008;63: 1241-5.
17. Baker P, Bodner E, Allman R. Measuring life-space mobility in community-dwelling older adults. J Am Geriatr Soc. 2003;51: 1610-14.
18. Allman R, Baker P, Maisiak R, Sims R, Roseman J. Racial similarities and differences in predictors of mobility change over eighteen months. J Gen Intern Med. 2004;19: 1118-26.
19. Allman R, Sawyer P, Roseman J. The UAB Study of Aging: background and insights into life-space mobility among older Americans in rural and urban settings. Aging Health. 2006;2: 417-29.
20. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992;326: 1187-91.
21. Steinkamp G, Wiedemann B. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Br Med J. 2002;57: 596.
22. Abbott J, Webb K, Dodd M. Quality of life in cystic fibrosis. J R Soc Med. 1997;90(Suppl. 31): 37-42.
23. Gilson BS, Gilson JS, Bergner M, etal. Sickness impact profile - development of an outcome measure of health-care. Am J Public Health. 1975;65: 1304-10.
24. Hunt SM, Mckenna SP, Mcewen J, Williams J, Papp E. The Nottingham Health Profile - subjective health-status and medical consultations. Soc Sci Med. 1981;15: 221-9.
25. Brazier JE, Harper R, Jones NMB, etal. Validating the SF-36 Health Survey Questionnaire - new outcome measure for primary care. Br Med J. 1992;305: 160-4.
26. Bell SC, Robinson PJ. Exacerbations in cystic fibrosis: 2. Prevention. Thorax. 2007;62: 723-32.
27. Pfeffer PE, Pfeffer JM, Hodson ME. The psychosocial and psychiatric side of cystic fibrosis in adolescents and adults. J Cyst Fibros. 2003;2: 61-8.
28. Abbott J, Dodd M, Bilton D, Webb AK. Treatment compliance in adults with cystic fibrosis. Thorax. 1994;49: 115-20.
29. Khazai NB, Judd SE, Jeng L, etal. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light. J Clin Endocrinol Metab. 2009;94(6): 2037-43.
30. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry, 2008 Annual Data Report. Bethesda, MD, CF Foundation, 2009.